Slager David Mark 13D and 13G filings for Vascular Biogenics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-01 4:20 pm Purchase |
2022-01-24 | 13G | Vascular Biogenics Ltd. VBLT |
Slager David Mark | 101,545 5.130% |
101,545 (New Position) |
Filing |